Navigation Links
VeroScience Late-Breaking Abstract on Cycloset (A Quick Release,Formulation of Bromocriptine Mesylate) Accepted for Poster,Presentation at American Diabetes Association 67th Scientific,Sessions

TIVERTON, R.I., June 18, 2007 /PRNewswire/ -- VeroScience, LLC, a privately held biotechnology and healthcare product development company, announced today that its late-breaking abstract has been accepted as a poster presentation at the 67th Scientific Sessions of the American Diabetes Association in Chicago, Ill. The abstract, entitled, "Effects of Timed Cycloset(TM) (A Quick Release Formulation of Bromocriptine Mesylate) Administration of Safety, Cardiovascular Event Rate, and Glycemic Control in Subjects with Type 2 Diabetes Receiving Diet, Oral Hypoglycemic, and/or Insulin Treatment Regimens," will be included in the category of Clinical Therapeutics/New Technology - Pharmacologic Treatment of Diabetes or its Complications and displayed Saturday, Sunday and Monday, June 23-25, in the General Poster Session in the Exhibit Hall.

VeroScience is also sponsoring a corporate symposium supported by its commercialization partner for Cycloset(TM), S2 Therapeutics, Inc., that will be held in conjunction with the American Diabetes Association's 67th Scientific Sessions. The symposium, entitled "Evolution, Hypothalamic Dopamine Neurochemistry, and Developing New Therapies for Insulin Resistance Syndrome and Type 2 Diabetes," will be held on Sunday, June 24th from 5:30-7:45 AM at the Hyatt Regency Chicago, Grand F/D South. Registration and breakfast are from 5:00-5:30 AM or you can register in advance at www.veroscience.com/ada2007registration.

Cycloset(TM), an oral, quick-release formulation of bromocriptine is a centrally-acting dopamine D2 receptor agonist that is being studied as a potential therapy in the treatment of type 2 diabetes.

VeroScience is a privately held biotechnology and healthcare product development company with main offices and laboratories in Tiverton, RI. VeroScience has a large patent portfolio tha t supports its preclinical and clinical development programs and product pipeline in the areas of metabolism, immunology, reproduction, and oncology. VeroScience leverages its intellectual property and products in out-licensing and collaborative arrangements with appropriate industry partners.

S2 Therapeutics, a privately held specialty pharmaceutical company headquartered in Bristol, TN, is the commercialization partner for Cycloset(TM) and is the holder of an exclusive global license for the manufacture, marketing and distribution of Cycloset(TM). S2 seeks opportunities in the pharmaceutical industry through in-licensing arrangements and acquisitions of novel branded prescription pharmaceutical products.


    Contacts:

    Feinstein Kean Healthcare

    Christine Cramer, 617-761-6736

    
 
christine.cramer@fkhealth.com

CONTACT: Christine Cramer of Feinstein Kean Healthcare, +1-617-761-6736,, for VeroScience, LLC christine.cramer@fkhealth.com

Web site: http://www.veroscience.com/ada2007registration/

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company


'"/>




Related medicine technology :

1. Pilot Phase 3 Results of NovaCardias KW-3902 for Acute Congestive Heart Failure Presented at Late-Breaking Session of Heart Failure Congress 2007
2. Cougar Biotechnology Presents Positive CB7630 Clinical Data at AACR Annual Meeting Late-Breaking Clinical Trials Session
3. VIVUS Announces Abstract Published at American Diabetes Association Scientific Sessions
4. Savient Pharmaceuticals Announces Acceptance of Two Gout-Related Abstracts for Poster Presentation at the European League Against Rheumatism (EULAR) 2007 Annual Congress
5. OXiGENE Abstracts Published in ASCO Program
6. Six Abstracts Featuring Exelixis Compounds Accepted At ASCO Conference
7. Genta Incorporated to Present Multiple Abstracts at the Annual Meeting of the American Society of Clinical Oncology
8. Bentley Late Breaking Abstract Accepted for Poster Presentation at American Diabetes Association Scientific Sessions
9. Pharmacyclics Announces Presentations and Published Abstracts on Xcytrin at The 2007 American Society of Clinical Oncology Annual Meeting
10. Pro-Pharmaceuticals to Present Abstract at the International Society of Oncodevelopmental Biology and Medicine Conference
11. SciClone Announces ZADAXIN and SCV-07 Abstracts Accepted at ASCO
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/7/2018)... ... ... Dr. B. Aviva Preminger, elite plastic surgeon of New York has joined the ... woman plastic surgeon specializing in cosmetic and reconstructive surgery of the face, breast, and ... lifestyle publication is privileged to present Dr. Preminger as a leading plastic surgeon and ...
(Date:10/6/2018)... ... October 06, 2018 , ... The global wellness industry grew ... $4.2 trillion in 2017, according to an in-depth research report, the 2018 Global ... all-new data on the ten markets that comprise the global wellness economy provides fresh ...
(Date:10/5/2018)... ... ... Shango Las Vegas dispensary will team with Ink Ribbon Foundation breast cancer charity ... to raise funds for the Las Vegas nonprofit group that helps women pay for ... After being spurned by three national and a few local charities devoted to helping ...
Breaking Medicine Technology:
(Date:10/13/2018)... ... , ... Convoy of Hope is positioned and ready to serve the communities ... the devastated Florida Panhandle to begin response operations following Hurricane Michael. Up to 50 ... provide supplies to those affected by the storm. , Hurricane Michael made landfall ...
(Date:10/11/2018)... ... October 11, 2018 , ... Cognosante, a leader in health ... leader in contact center monitoring and quality assurance. , Inspired by ... supports alternative work environments and flexible schedules, providing remote job opportunities to an ...
(Date:10/11/2018)... ... October 11, 2018 , ... Bizmatics Inc. ... all sizes and specialties. PrognoCIS , their Health IT Software – provides ... , Greater Houston Healthconnect (GHH), the region’s health information exchange (HIE), serves 24 ...
(Date:10/6/2018)... ... October 06, 2018 , ... Jose Rodriguez- Feliz M.D is ... Haute Beauty, well known for their exclusivity, and luxurious lifestyle publication is privileged ... newest addition to the Haute Living network. , Haute Beauty consists of ...
(Date:10/5/2018)... ... ... Headquartered in Bedford Park, Illinois, United Security Health & Casualty ’s ... Department of Health and Human Services released a new rule regarding short ... which takes effect on October 2, 2018, is increasing the maximum duration of short ...
Breaking Medicine News(10 mins):